Sarepta Therapeutics (SRPT) PT Lowered to $75 at Needham & Company; 'FY17 Guidance Significantly Below Expectations'

Go back to Sarepta Therapeutics (SRPT) PT Lowered to $75 at Needham & Company; 'FY17 Guidance Significantly Below Expectations'
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 17.26 --0 (-0%)
Previous Close $17.26    52 Week High $63.73 
Open $17.26    52 Week Low $8.00 
Day High $17.26    P/E N/A 
Day Low $17.26    EPS $-5.69 
Volume 770